Alex Salcedo Email and Phone Number
I am a senior Finance, Strategy and Operations leader with over 15 years’ experience guiding executive teams, Boards, government agencies, and operational teams in business sustainability and expansion across diverse organizations: Fortune 100’s, startups, private equity, and non-profits. I develop future business strategy, manage execution and cultivate an accountable, resilient culture that inspires positive behavioral change. My professional history is progressive, spanning the financial, life sciences and emerging technology industries.ACHIEVEMENTS• Co-Founder and CFO of biotech company leading treatment of debilitating oral conditions caused by cancer.• Managed business transformation of NJ’s largest developmental disabilities service provider.• Underwrote $400M in equity, debt and real estate transactions.• Valued 300+ private equity portfolio companies worth $30B.• Developed and managed merger and acquisition, organic growth, valuation, economic, and GAAP modeling across multiple asset classes.• Controller for $1.4B in IT implementation projects.I translate complex concepts and deliver data-driven presentations. Continually focused on building cross-functional collaboration and team synergy, I model facilitative leadership, transparency and commitment to business objectives. I see conflict not as a problem, but an opportunity to discover solutions.STRENGTHSThought LeadershipHigh Performing Team DevelopmentTurnaroundsFinance, Planning and AnalysisControllership and Administrative LeadershipInvestment ValuationLean Process ImprovementsSix SigmaPolicies and Procedures (For-Profit, Non-Profit, Govt Sectors)Bond IssuanceMergers and AcquisitionsMerger IntegrationProgram and Project ManagementEnterprise ReorganizationCarve-Outs / IPOs / SEC ReportingLife SciencesBiotechAs a team advocate, coach and mentor, I am committed to professional and personal development. I also serve as adjunct professor at Rutgers Business School teaching Global Corporate Strategy and M&A. Email: alexeysalcedo@gmail.comCell: 201-370-1455
Meadowland Capital Management, Inc.
View- Website:
- email.meadowlandcapital.com
- Employees:
- 1
-
Operating Partner (Interim And Fractional Cfo)Meadowland Capital Management, Inc.New York, Ny, Us -
Chief Financial OfficerMeadowland Capital Management, Inc.New York, Ny, Us -
Vice President FinanceAspire Pharmaceuticals Jul 2024 - PresentSomerset, Nj, Us -
Board AdvisorNeobex Therapeutics 2023 - PresentBiopharma company focused on treating debilitating oral and gastrointestinal conditions• Help to lead business formation and integration of a portfolio of biopharmaceutical drugs for treatment of oral mucositis (AGT-1) and Interstitial Cystitis (UrobexTM) with a $2.0B global market opportunity.• Co-lead $6M fundraising initiative to provide drug pipeline financing for AGT-1 Phase II(b) clinical trials directed towards completion of protocol development, UrobexTM CMC (Chemistry, Manufacturing, and Controls), and subsequent FDA approvals.
-
Consulting Chief Financial OfficerEscalon Services, Inc. Jan 2022 - Jul 2024Palo Alto, Ca, UsEarly Growth is the largest national provider of outsourced CFO & accounting services in the venture capital space. For over 10 years, Early Growth has been providing finance & accounting, tax, equity management, and fund accounting services to startups at all stages. Early Growth is a strategic partner handling your finances so you can focus on your business, customers, and team. As an experienced CFO with a specialization in medical device, genomics and biotech, I enjoy serving early-stage life sciences and emerging technology companies (and leaders) and positioning them for growth and sustainability. I appreciate the unique challenges and opportunities each company faces and my job is to assure business financial health and growth. Partnering with business owners and leadership, I bring unified structure and purpose to departments and teams in the following areas:• Corporate Development• Finance• Accounting• Compliance• Tax• Financial Planning & Analysis (FP&A) Because adaptability is key in today’s business environment, I ensure these foundational operations are built to scale and prepare teams and leadership to drive forward with power and purpose. CLIENT SAMPLEEvident Vascular Inc.: Medical Imaging & DiagnosticsRavel Biotechnology: DNA Disease Detection / BioinformaticsAlimetry, Inc.: GastroenterologyArgo Space Corp: In-space transportation network (GEO), moon water harvesting -
Interim Chief Financial OfficerMeadowland Capital Management, Inc. 2022 - Dec 2023Montclair, Nj, UsAdvisory Services firm serving life science and emerging technology companiesMy role as a CFO involves diverse companies and industries on interim basis. I’m skilled in walking into an organization, unraveling the complexities of business finance and identifying opportunities to elevate the business. APPROACH PATHS• Relationship Management• Performance Improvement• Mergers & Acquisition (M&A) Strategy and Positioning• Financial Modeling & Analysis• Refinancing• New Facility Financing• Due Diligence• Strategy Financial Planning CLIENT SAMPLE• Medical Device Company ($25M in Sales): I played a crucial role in driving Extremity Medical's growth and financial success in the highly competitive medical device industry.¬ Drove performance improvement initiatives across the company, creating strategy to consolidate and integrate the company's tech stack, spearheading an audit readiness initiative, championing a cap table management system, driving a 20% operating cost reduction target, while making company more attractive to potential acquirers. ¬ Guided M&A strategy, managing financial model development, and facilitating introductions to M&A advisors within the medical device orthopedic lower middle market sector.¬ Led a $15M refinancing and new facility initiative to better capitalize the company for growth. • Biotech Company ($20M): Transitioned from a full-time biotech CFO role to an interim engagement, providing advisory services as needed. • High-Speed Trading & Crypto Currency brokerage firm($30M in sales): Managed transitional CFO initiative functions inclusive of finance, accounting and reporting, banking, and audit, as well as tax relationships. -
Chief Financial Officer, Board Member, TreasurerApplied Glycan Technologies 2017 - Jan 2022New York, Ny, UsI was pleased to lead the executive team and Board in the startup of this life-enhancing biotechnology, pharma company that is focused on the treatment of debilitating oral conditions caused by head and neck cancer. As Applied Glycan’s Chief Financial Officer, Treasurer and Board of Directors member, I advise leadership and manage execution of all activities related to business launch, capital financing strategy and implementation of the operational infrastructure. • Establish sustainable, adaptive operations, processes, and policies and procedures, ensuring capacity for business development and market expansion.- Budgeting- Taxes- Finance- Fundraising- Accounting Operations- Grant Fund Accounting and Controls- Valuations - Nomination Committee – Board Member selection• Facilitate long-term fundraising through government grants and private investors, creating and implementing corporate governance and internal operations control measures.• Sourced and secured a Top 5 New Jersey accounting and global risk assurance firm to provide advisory services, negotiating exceptionally favorable pricing.• Cultivated relationships for the engagement of the 2 largest company investors, driving the private equity and angel investor fundraising process.• Ensure regulatory compliance of Federal Acquisition Reporting (FAR) by outsourcing accounting to the country’s leading Grant Fund Account firm.• Position company to receive $3.3M in government funding. Help lead multi-disciplinary collaboration to complete SBIR filing requirements early to achieve timely submission.• Secured pro bono expert review that resulted in refining a key indirect rate calculation. This enabled successful filing of a $6M 3-year Small Business Innovation Research (SBIR) Budget application filing to the National Institute of Health (NIH) and the National Cancer Institute (NCI). -
Vice President Of Finance And OperationsMeadowland Capital Management, Inc. 2018 - Mar 2020Montclair, Nj, UsI serve multiple industries and companies, including organizations in the life science, emerging tech and alternative investment (private equity and portfolio companies) spaces. My focus is to facilitate strategy and business transformation involving reorganization, continual improvement, merger and acquisition integration, government policy, bond issuance, and accounting operations. LEAN PROCESS IMPROVEMENTS | ORGANIZATIONAL REALIGNMENT | INTERNAL CONTROLS• Orchestrated Financial Transformation and Organizational Restructuring as Program Manager for Easterseals New Jersey.• Co-led development and execution of realignment strategy and planning and Lean process improvements, including change management messaging and training.• Managed 10 departments in development and production of company-wide standard operating procedures, and consumer and employee guides.• Drove 53% decrease in Full-Time Employee (FTE) processing time through Kaizen events and DILO analysis. • Integrated all IT systems [Electronic Healthcare Record (EHR), Human Capital Management (HCM), Payroll, and Fund Accounting (MIP) systems] with middleware platform. Led the digitization of the following business processes:- Applications- Enrollment- Payroll- T and E Expense Vouchers- Monthly ReportingPOLICIES AND PROCEDURES | GOVERNMENT SERVICES• Achieved M&A integration success as executive member of KPMG Advisory Services Team driving process flow efficiency of New York Power Authority (NYPA) subsidiary.- Conducted operational assessment and identified improvement opportunities, culminating in integration strategy.- Delivered strategic analytics illustrating A/R aging collections reductions and write-offs, and providing sourcing options, potentially increasing receivable capture 40%. -
Vice President Of Corporate FinanceMeadowland Capital Management, Inc. 2017 - 2018Montclair, Nj, UsI provided M&A Advisory, audit readiness and technical accounting services for clients. BOND ISSUANCE | MERGER-INTEGRATION | TECHNICAL ACCOUNTING• Spearheaded $400M bond offering initiative for proton cancer treatment center, building 5-year financial forecast model, restructuring debt, converting this for-profit to a non-profit entity .• Developed and executed successful $300M merger transaction agreement plan.• Led the development of the board presentation and review of the Asset Coverage Ratio Calculation for Senior Secured Loan Maintenance Covenant on behalf of Ligado Networks, a satellite communications company (Broadband Services).• Saved client $12K in research costs by building 3 Spectrum Auction presentation models.- Integrated all FCC and Government of Canada data.- Validated revision of the prior year’s Asset Coverage Ration presentation.• Developed strategic relationships and designed roll-out plan to acquire NYC office space. Led FEI/ACG business development initiatives, laying the foundation for ASC-606 and Pre-IPO Readiness. -
Vice President Of FinanceMeadowland Capital Management, Inc. 2010 - 2017Montclair, Nj, UsREGULATORY REPORTING | COMPLIANCE | CARVE-OUT | IPO• Managed regulatory reporting for 9 investment entities with $12B AUM, reducing errors and auditor review time by 4 days through process automation.• Directed $50B Private Equity Fund process improvement and IT migration controls initiative for Sculpture Capital Management.- Reduced monthly reporting time by 15 days.- Automated hybrid and real estate private equity allocation models and created cash flow waterfall structures.• Drove $65M initial public offering (IPO) of Bellerophon Therapeutics, a Biotech spinoff. - Led the carve-out from parent company (Ikaria) Research and Development group.- Completed S-1, 10K and 10K SEC public filings, leading to IPO.ASSURANCE SERVICES | TAXES• Advised PwC (PricewaterhouseCoopers) audit teams in full audit life cycle for 10 emerging market private equity funds.• Led the investment valuation process representing $900M AUM, reviewing 12 portfolio organizations in Asia, Europe and Latin America.FINANCE AND ADMINISTRATION | MERGERS AND ACQUISITIONS • Developed, implemented and managed all finance and accounting functions for MCM inclusive of:- Financial Reporting- Accounting- Tax- Audit- Capital Procurement- Invoicing- Contractual Governance- Funding• Financed acquisition and managed major capital projects renovation of distressed property.- Created build-hold strategy to later develop adjoining properties into new construction multi-unit sale. - Projected 5-yr 50% IRR, while receiving 100% COC return in 17 months. • Directed Merger and Acquisition initiatives for Celgene-sponsored Biotech startup (Celularity).- Decreased acquisition costs by $7M, implementing a milestone incentive payout structure and reduced pricing.- Facilitated the purchase of a company providing the highest quality biomaterials (stem cells) by leveraging GAAP small business valuation to guide negotiations with the largest, most reputable supplier. -
Adjunct ProfessorRutgers Business School May 2014 - Jan 2015Newark, Nj, UsInstructed MBA program executive professionals in the strategic nuances and reality of:• Global Management Strategy - How to implement and navigate multidimensional, distributed and interdependent, and flexibly integrated strategic business service models in a global environment.• Mergers, Acquisitions, and Strategic Alliances - Use in-depth case study review of valuations, merger integration, negotiations, deal structuring, corporate venturing, and alliances to drive home the complexity of corporate M&A. -
Director Of FinanceResources Global Professionals 2005 - 2010Irvine, Ca, UsCLIENTS: Goldman Sachs, Credit Suisse, Apollo Global Management, FriedbergMilstein, DTCC Post-Merger Integration | Valuations | Financial Reporting | Performance AnalyticsServing in various progressive roles at RGP, formerly a unit of Deloitte and Touche, LLP, I orchestrated significant business impact in client and revenue growth, M&A integration, business strategy, financial planning, and operational planning.• Co-led team of 7 professionals conducting valuations and financial reporting for 460 funds in a fund of funds group with $20B AUM. • Decreased quarterly cycle time by 25 days while growing unit from 1 to 12 employees in 1.5 years.• Advised PE firm with 4 LBO funds representing $10B AUM, providing board-level consulting services for portfolio valuation.• Instituted comprehensive board reviews and assembled a performance analytics group for $250M CDO fund.- Led evaluation of 30 companies to include investment memos, bank books, financials, agreements, agency reports, and current events. -
ControllerResources Global Professionals 2008 - 2009Irvine, Ca, UsCLIENTS:Dune Capital ManagementDIVESTITUREAs Controller serving an RGP client company founded by the previous U.S. Treasury Secretary, I directed hedge fund divestiture and led cash position improvement efforts and business development.• Guided divestiture, management, operational and process improvement initiatives.- Directed $3B hedge fund divestiture while managing business, investment and operating activity.- Reduced workforce costs 75%.- Decreased salary expenses by $450k by restructuring staff positions.• Enhanced company’s cash position by $1B, preserving LP relationships, by driving the sale of various liquid asset positions over 10 months. -
Director Of Financial Planning And Analysis (Fp&A)Resources Global Professionals 2005 - 2006Irvine, Ca, UsCLIENTS:ADP Post-Merger Integration | Valuations | Financial Reporting | Performance AnalyticsLed ADP post-merger integration, reducing operational costs and increasing revenue through strategy, planning and focused execution.• Drove $400M in revenue growth while decreasing operating expenses by 10%.• Led Financial Planning and Analysis (FP&A) effort, aiding transition to new accounting system, and integration of various departments into parent company• Initiated 5-year Strategic and Operational Plans, building revenue and expense models, facilitating reconciliation with the general ledger by account. -
Senior Manager Corporate Strategy And DevelopmentResources Global Professionals 2004 - 2005Irvine, Ca, UsCLIENTS:MetLife Bank, RGPI served as the global senior strategy leader to corporate client MetLife Bank and RGP, directing organic growth and new business development initiatives that led to disruptive organizational changes, resulting in significant cost reductions, culture transformation and new business growth.Cross-Selling | Up-Selling• Led development of global business strategy and comprehensive culture change.• Directed launch of MetLife Bank mortgage business, producing $50M in new segment revenue by cross-selling to existing insurance customer base.• Conceived, designed, and implemented 100-day post-acquisition service line, upselling to existing private equity customer base while optimizing use of intellectual capital of 4,500 consultants globally. -
Chief Financial Officer - (Nyc Chapter)Prospanica Fka Nshmba 2003 - 2005Dallas, Texas, UsLed the New York City Chapter in planning and executing growth strategy and operational budget forecasting and management. • Managed financial reporting, vendor procurement, contract negotiations, event programming, and fundraising, ensuring policy management and legal compliance.• Identified opportunity to involve leading hispanic professionals and expand chapter membership. - Conceptualized, planned and led hispanic professional business events.- Influenced business community support by providing corporate sponsor ROI. - Increased NYC Chapter membership from 600 to 800 members. -
Independent ConsultantReal Estate Private Equity Services 2003 - 2004CLIENT:PGIM Real Estate (f/k/a PREI)Led the firm in developing transaction models to identify FIN 46 impact for joint ventures involving government buildings and apartment complexes, and public storage facility private equity transactions with some of the largest commercial real estate developers in the nation. • Modeled 50 real estate joint venture and private equity transactions for firm with $2B AUM, evaluating every level of the cash flow waterfall structure for economic and voting interest.• Delivered financial statement impact and effective decision-making capacity, while working with PwC audit team.
-
Assistant Vice President, Transaction ServicesGe Capital Corp 2001 - 2003Boston, Ma, UsManaged large debt portfolio and underwrote transactions in the manufacturing, energy, tobacco, and luxury markets.• Guided the underwriting process for debt transactions valued at $300M in volume, including structuring term loans, capex loans, revolvers, operating and synthetic leases, and subordinated debt.• Led the analysis and reporting of loan portfolio, evaluating performance, liquidity, and exit strategy, managing the financial performance of $195M portfolio account. -
Associate, Corporate Development GroupConseco Private Capital Group, Inc. 2000 - 2001Carmel, Indiana, UsContributed to new investment opportunity underwriting for startup and middle market companies in the technology, financial, real estate and gaming industries.• Supported assessment of potential mergers, acquisitions, and strategic investments, quantifying risks and assisting in deal structuring.• Underwrote equity transactions valued at $100M, involving investments in digital currency, gaming, emerging technology, low-earth orbit satellite systems, horse racing, and real estate resort development sectors.• Performed due diligence, modeling, valuation and structuring analysis, facilitating preparation and negotiation of financial and legal documents. • Drafted term sheets and analyzed investment terms including provisions covering governance and liquidity events. • Wrote investment committee memorandums. -
Global Project ControllerAccenture 1999 - 2000Dublin 2, IeCLIENTS:AT&T, LTV SteelServed as CFO for enterprise Information Technology (IT) project engagements.• Won new integration and outsourcing contracts valued at $50M.• Guided financial oversight of large IT infrastructure initiatives and processing of monthly financial statement presentation, forecasting, cash flow analysis, aging of receivables, billing, contractor accruals, time reports, and expense audits.• Served as portable CFO:- $170M AT&T E-billing system projects- $1B LTV Steel SAP/Y2K/Outsourcing projects. -
Manager, Corporate StrategyAccenture 1998 - 1999Dublin 2, IeGuided global strategic planning to drive internal post-merger integration between Client Financial Management (CFM - Business Practices Unit) and BPM (Business Process Unit), involving organizational restructuring, headcount, revenue, training, attrition, and payroll expenses.• Spearheaded global strategic planning process to merge the Business Practices Unit with the Business Process Outsourcing Division.• Led restructuring planning and execution including workforce management, revenue management, learning and development, and payroll expense management for $90M business unit. -
Management Consultant, Financial AnalystRobert Half Management Resources 1994 - 1998Menlo Park, Ca, UsCLIENT:Reckitt Benckiser Group, plcSupported subsidiary merger for $5B Consumer Products Goods (CPG) company.• Developed cross-functional collaboration with the Marketing and Finance departments, ensuring reliable, accurate data.• Led the Finance business unit in creating workflow efficiency and improving MIS and internal controls, driving 50% increase in productivity and accuracy.• Designed financial models, synthesized information and consolidated financial statement presentation, resulting in concise, clear delivery and actionable data for decision making. • Implemented use of Hyperion Pillar reporting system, facilitating accurate, timely data and budget reporting. -
Superintendent, Field Engineer - Life Science And Healthcare Service SectorsTurner Construction Company 1990 - 1993New York, Ny, UsCLIENTS: Englewood Hospital, Johnson & Johnson (J&J)• Supervised 60 union contractors in specialized hospital room construction (Cardiac Cathedization, Radiation Therapy, Nursery Wing) and medical equipment installation. Led teams in the development and tenant fit out of administrative facilities.• Assisted in the management of 160 union contractors in various phases of construction of biotech facility.• Built one of the United State’s first FDA approved biomedical pharmaceutical manufacturing/production facility for J&J subsidiary .
Alex Salcedo Education Details
-
Rutgers Business SchoolFinance And Accounting -
Rutgers UniversityCivil Engineering -
Harvard Business SchoolExecutive Education Program – Mergers And Acquisitions -
Harvard Law SchoolNegotiation Program For Senior Level Managers -
New York UniversityCertificate In Investment Banking -
Suny Levin InstituteIntegration Of Mobile Technology In Healthcare And Microwork Service Platforms -
New York Institute Of FinanceComplex Leveraged Buyout Modeling
Frequently Asked Questions about Alex Salcedo
What company does Alex Salcedo work for?
Alex Salcedo works for Meadowland Capital Management, Inc.
What is Alex Salcedo's role at the current company?
Alex Salcedo's current role is Operating Partner (Interim and Fractional CFO).
What schools did Alex Salcedo attend?
Alex Salcedo attended Rutgers Business School, Rutgers University, Harvard Business School, Harvard Law School, New York University, Suny Levin Institute, New York Institute Of Finance.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial